FENSOLVI KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fensolvi Kit, and when can generic versions of Fensolvi Kit launch?
Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. There is one patent protecting this drug.
This drug has ten patent family members in ten countries.
The generic ingredient in FENSOLVI KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fensolvi Kit
A generic version of FENSOLVI KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for FENSOLVI KIT
International Patents: | 10 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FENSOLVI KIT |
DailyMed Link: | FENSOLVI KIT at DailyMed |
Pharmacology for FENSOLVI KIT
Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
US Patents and Regulatory Information for FENSOLVI KIT
FENSOLVI KIT is protected by one US patents.
Patents protecting FENSOLVI KIT
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FENSOLVI KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Try a Trial | ⤷ Try a Trial |
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Try a Trial | ⤷ Try a Trial |
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FENSOLVI KIT
See the table below for patents covering FENSOLVI KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 287528 | ⤷ Try a Trial | |
Japan | 6087886 | ⤷ Try a Trial | |
Canada | 2436275 | FORMULATIONS D'ADMINISTRATION DE LEUPROLIDE PAR POLYMERE AVEC UNE EFFICACITE ACCRUE (POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY) | ⤷ Try a Trial |
Slovenia | 1322286 | ⤷ Try a Trial | |
Japan | 2014240439 | 改良された効力を備えた、ロイプロリドのポリマー送達処方物 (POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY) | ⤷ Try a Trial |
China | 100536922 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |